Bruce Wendel - Nov 16, 2020 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Director
Signature
Bruce Wendel
Stock symbol
GTBP
Transactions as of
Nov 16, 2020
Transactions value $
$26,299
Form type
4
Date filed
10/7/2021, 02:47 PM
Previous filing
Oct 7, 2021
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTBP Common Stock Purchase $10.3K +3.27K $3.14* 3.27K Nov 16, 2020 Direct
transaction GTBP Common Stock Purchase $12.2K +1.37K +42.04% $8.87* 4.64K Dec 22, 2020 Direct
transaction GTBP Common Stock Purchase $3.85K +441 +9.5% $8.73* 5.08K Dec 22, 2020 Direct
transaction GTBP Common Stock Award $0 +348K +6837.93% $0.00 353K Feb 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50K $0.00 50K Feb 16, 2021 Common Stock 50K $6.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022.
F2 1/3rd of the shares vest on February 16, 2021, 2022, and 2023.